The possible contributions of the angiotensin receptor subtypes 1 (AT 1 ) and 2 (AT 2 ) to angiotensin II (Ang II)induced changes in collagen secretion and production were studied using the specific angiotensin AT 1 -and AT 2 -receptor antagonists telmisartan and P-186, respectively. Cardiac fibroblasts (from normal male adult rats) from passage 2 were cultured to confluency and incubated in the presence of 10 -10 to 10 -6 M Ang II in serum-free Dulbecco's MEM medium for 24 hours. Collagen production and secretion were assayed by 3 H-Proline incorporation; non-collagen production and secretion were also calculated. Ang II dose-dependently increased collagen secretion and production in rat adult cardiac fibroblasts in culture. Non-collagen secretion and production were also concentration-dependently increased by Ang II. Addition of 100 nmol/l Ang II increased (p<0.01) collagen secretion and production by 75±6 (SEM)% and 113±23%, respectively, and non-collagen secretion and production by 65±6% and 57±16%, respectively. Pretreatment of cardiac fibroblasts with telmisartan completely blocked the Ang II-induced increase in collagen secretion (p<0.001) and production (p<0.05) and in non-collagen secretion (p<0.01) and production (p<0.01). P-186 had no effect on the Ang IIinduced increase in collagen secretion and production. Addition of telmisartan and P-186 did not affect collagen secretion and production in basal cardiac fibroblasts. Our data demonstrate that the effects of Ang II on collagen secretion and production in adult rat cardiac fibroblasts in culture are AT 1 -receptor mediated, since they were abolished by the specific AT 1 -receptor antagonist, telmisartan, but not by the specific AT 2 -receptor antagonist, P-186.
Introduction
The renin-angiotensin system (RAS) has emerged as a potential candidate mediating the accumulation of collagen in cardiac fibroblasts. 1 The traditional RAS can be considered a system in which circulating angiotensin II (Ang II) is delivered to target tissue or cells. However, an independent local RAS has also been described in cardiac cells and evidence has been accumulating for autocrine, intracrine and/or paracrine pathways by which the biological actions of Ang II can be mediated. [2] [3] [4] [5] [6] [7] These actions of Ang II are primarily mediated by Ang II subtype 1 (AT 1 ) receptors.
To examine the effect of Ang II on collagen synthesis and/or degradation in serum-deprived cultured rat cardiac fibroblasts, a cell culture tech-nique was selected to eliminate numerous confounding influences present in vivo, including haemodynamic factors and interactions between the RAS and other humoral regulatory systems, such as kinin-prostaglandin and adrenergic systems, each of which can influence myocardial collagen metabolism. 8, 9 Furthermore, several growth factors are known to stimulate fibroblastmediated collagen synthesis, such as transforming growth factor-β 1 (TGF-β 1 ), platelet-derived growth factor and insulin-like growth factor. 10, 11 Discrepant findings 12 regarding the effect of Ang II on the total collagen synthesis in adult rat cardiac fibroblasts have been reported (Table 1) . At 10 -7 M,Ang II increases total collagen synthesis in cardiac fibroblasts cultured for 24 hours in serum-free medium. 13, [15] [16] [17] [18] [19] However, at 10 -9 M Ang II, Villareal et al. 14 found a significant increase (+30%) in total collagen synthesis which was completely abolished by losartan (10 -6 M), while Brilla et al. 16, 17 found no effect of 10 -9 M Ang II on total collagen synthesis in cultured cardiac fibroblasts.
The increase in total collagen synthesis induced by 10 -7 -10 -6 M Ang II was shown to be completely abolished by 10 -5 M losartan, 16 by 10 -6 M losartan 18, 19 and by 10 -5 M PD 123177. 16 However, Brilla et al. 17 found a significant increase in total collagen synthesis by 10 -7 -10 -6 M Ang II which was completely blocked by 10 -9 M candesartan, but not by 10 -9 M PD 123177.
In the present study, the concentration-dependency of Ang II on collagen secretion and collagen production was investigated in adult rat cardiac fibroblasts in culture.
The possible contributions of the angiotensin receptor subtype 1 (AT 1 ) and 2 (AT 2 ) on Ang IIinduced changes in collagen secretion and production in adult rat cardiac fibroblasts in culture were studied using the specific angiotensin AT 1 -and AT 2receptor antagonists, telmisartan and P-186, respectively.
(Natick, Massachusetts, USA Transforming growth factor-β 1 was obtained from Becton Dickinson Immunocytochemistry System (San Jose, CA, USA).
Isolation of cardiac fibroblasts
Cardiac ventricular fibroblasts were obtained from male Wistar rats, seven to eight weeks old and weighing about 200 g, using a slightly modified isolation procedure as described by Brilla et al. 16 In brief, rats were heparinised (625 units/100 g body weight) and anaesthetised intraperitonially with nembutal, 50 mg/100 g body weight. The heart was removed and placed immediately in sterile Joklik's medium.The extirpated hearts were allowed to eject the residual blood and the aorta was connected with a cannula. This was flushed with a few ml of basic salt solution containing NaCl 130 mM, KCl 3 mM, KH 2 PO 4 1.2 mM, MgSO 4 1 mM, CaCl 2 1.25 mM, glucose 10 mM, HEPES 10 mM, pH 7.2 to rinse any residual blood out of the heart. The hearts were then perfused via the ascending aorta according to the Langendorff method 20 with Joklik's medium for 5 minutes, then by recirculating Joklik's medium containing 0.02% collagenase A and 2% bovine serum albumin (BSA) for 35 minutes with a flow of 5 ml/minute. Thereafter, the atria and vessels were removed and the ventricular tissue was placed in Joklik's medium containing 1% BSA and 0.01% collagenase A for an additional 10 minutes (37°C). The tissue was then minced and filtered through a 200 µM mesh net.
Cell cultures
The coarse cell/disintegrated tissue suspension was settled for 15 minutes and its supernatant then centrifuged at 350 g for 10 minutes. The pellet was resuspended in DMEM supplemented with 10% foetal bovine serum (FBS) and 1% penicillin/streptomycin solution and seeded in a 80 cm 2 tissue culture flask.The cell cultures were then preincubated at 37°C in humidified air (humidity 95%) with 5% CO 2 for 4 hours. The medium with unattached cells was then aspirated and fresh DMEM, supplemented with 10% FBS and penicillin/streptomycin, added.The cultures were examined daily using phase contrast microscopy. The medium was replaced every two to three days and the cells were grown to confluence and then passaged with trypsin-EDTA. Under the above-mentioned conditions of isolation, coronary smooth muscle and endothelial cells are already rarely seen in the primary cultures. Myocytes do not survive the isolation method since oxygenation is not provided. In the present study, only cardiac fibroblasts from passage 2 were used. For the second passage, cells were transferred to 6-well dishes in DMEM with 10% FBS at a density of 2600 cells/dish for three days. The medium was then replaced with fresh DMEM with 0% FBS for three days.
The cells were then preincubated with and without telmisartan (10 -7 M) or P-186 (10 -7 M) for 1 hour and then further incubated with and without Ang II (10 -10 to 10 -6 M) for 24 hours in serum-free DMEM.
Assay of collagen secretion and production
Collagen secretion and production were mea-118 PAPER Brilla et al. 16 SD 10 -11 -10 -9 24 no effect --10 -7 -10 -6 24 +82% completely abolished completely abolished (p<0.005) by losartan (10 -6 M) by PD 123177 (10 -5 M)
Brilla et al. 17 SD 10 -11 -10 -9 24 no effect --10 -7 -10 -6 24 +82% (p<0.005) completely abolished no effect of by candesartan (10 -9 M) PD 123177 (10 -9 M)
Lijnen et al. 18 Wistar 10 -6 24 +91% completely abolished by -Petrov et al. 19 (p<0.05) losartan ( sured according to the method of Peterkovsky. 21 After aspiration of the medium, the cells were washed twice with serum-free DMEM. Serum-free DMEM 900 µl, containing an inhibitor of lysyl oxidase (β-aminopropionitrile 0.1 mM) and an activator of proline hydroxylation (ascorbic acid 50 µg/ml) was then added and the cells were incubated at 37°C for 15 minutes. [5-3 H]-Proline (1 mCi), up to a final activity of 21 µCi/ml, was then added and the cells further incubated for 4 hours. The dishes were chilled on ice and the medium was removed and placed in A-tubes for measurement of soluble collagen.
To each well, 1 ml of a solution containing 110 m NaCl, 50 mM Tris-HCl pH 7.4 and 10 mM proline was added and the cells were scraped off. The suspension was removed and placed in Btubes or measurement of insoluble collagen. The wells were rinsed with 1 ml of the same saline solution and the rinse added to the suspension. The suspension was centrifuged at 24,000 g at 4°C for 5 minutes. The supernatant was added to the medium (A-tube). To the cell pellets (B-tube), 0.5 ml of a solution containing 400 mM NaCl, 100 mM N-(2hydroxyethyl)piperazine-N'-4-butanesulfonic acid (HEPES), pH 7.2, and 10 mM proline were added.
The cell suspension was sonicated twice at 20% of the maximum voltage time for 20 seconds, while keeping the tubes in iced water. The proteins in the sonicates of the pellets (B-tubes) were precipitated with 0.5 ml of a solution containing 20% trichloroacetic acid (TCA) and 20 mM proline. To the medium (A-tubes), 0.15 ml of a solution containing BSA, 10 mg/ml, as a carrier protein and 0.79 ml of a solution containing 50% TCA and 50 mM proline were added.
The pellets were dissolved in 0.6 ml of 200 mM NaOH and 0.2 ml of each sample was transferred to conical Eppendorf tubes. The solution in each tube was neutralised by a solution containing 150 mM HCl and 1000 mM HEPES pH 7.2. The final pH should be between 6.8 and 7.4; therefore the pH in each tube was checked using pH-paper. To each A-and B-tube, was added 40 µl of a solution containing: 1) highly purified collagenase VII 8 µg in 10 µl of the elution buffer or 10 µl of the elution buffer, 2) 25 mM CaCl 2 (to increase the activity of collagenase VII), 3) 20 µl of 62.5 mM N-ethylmaleïmide (NEM) (to inhibit the activity of nonspecific proteases, mainly clostripain). The tubes were incubated at 37°C for 1.5 hour. After this incubation, the tubes were chilled on ice. To each tube, 0.5 ml of an ice-cold solution containing 10% TCA and 0.5% tannic acid was added. After incubation on ice for 5 minutes, the tubes were centrifuged at 24,000 g at 4°C for 5 minutes. The supernatant was placed into vials with 9 ml of scintillation fluid.
For measurement of the non-collagen protein synthesis, the pellets which were treated with collagenase VII were resuspended in 0.8 ml of a 6 M HCl solution, transferred into screw-capped glass tubes and heated at 150°C for 30 minutes. 0.2 ml of the hydrolysate was transferred into vials containing 9 ml of scintillation fluid. Radioactivity was measured in a liquid scintillation counter (Tri-Card Model A, Canberra Packard, Benelux NV) for 5 minutes.The collagen secretion and production were expressed as dpm/10 6 cells.
Immunocytochemistry
Immunofluorescence was performed in slides (Becton-Dickinson). The cells were fixed in methanol at -20°C for 5 minutes. After blocking non-specific binding with 0.5% BSA, the cells were incubated at 37°C for 1 hour with primary antibodies (Ab) : monoclonal mouse anti-vimentin Ab. clone V9 (Dako, Glosstrud, Denmark) diluted 1/10; monoclonal mouse anti-desmin Ab (Dako), clone D33, diluted 1/10, or nonclonal mouse anti-factor VIII Ab (Dako), clone F8/86, diluted 1/10. The cells were then washed with phosphate-buffered saline and further incubated for 1 hour with an antimouse IgG, conjugated with fluoresceine isothiocyanate (Sigma Chem. Co.), diluted 1/100. Secondary Ab was also added to cells without primary antibody, to check for non-specific binding. Finally, the cells were washed with phosphate-buffered saline and mounted in Moviol, solved in Tris HCl buffer (pH 8.5) with glycerol and n-propyl gallate. Visualisation was performed by the use of an inverted Leica-Leitz microscope DMIRB (Leica AG, Heerbrugg, Switzerland) and the cells were photographed on Fujicolor CZ 135. Our cell cultures contain vimentin, a marker of fibroblasts-like cells, but do not contain desmin or factor VIII, markers of VSMC and endothelial cells, respectively. In the initial phases the cultures contain more elongated cells. As cultures approach confluence more cells with stellar shape appear and in confluent cultures round cells appear. Thus, our cultures consist of fibroblast-like cells and are free of VSMC and endothelial cells.
Statistical analysis
Values are expressed as mean±SEM.The statistical methods used were repeated measures of variance (Turkey's) and Student's t-test for paired data when appropriate and p<0.05 was considered statistically significant.
Results

Effect of Ang II on collagen production and secretion
As shown in Figure 1 , Ang II dose-dependently increased collagen secretion and production in rat cardiac fibroblasts in culture. Non-collagen secretion and production were also concentration-dependently increased by Ang II (Figure 2 ). Addition of 10 -7 M Ang II increased (p<0.01) collagen secretion and production by 75±6% and 113±23%, respectively and the non-collagen secretion and production by 65±6% and 57±16%, respectively.
Effect of Ang II receptor antagonists on Ang II-induced rise in collagen
Addition of telmisartan (10 -7 M) and P-186 (10 -7 M), alone or together, did not affect collagen secretion and production in basal cardiac fibroblasts ( Figure  3 and 4 ). Pretreatment of cultured cardiac fibroblasts with the Ang II AT 1 -receptor antagonist, telmisartan (10 -7 M), completely blocked the Ang II (10 -7 M)-induced increase in collagen secretion and production (Figures 3 and 4) .When the Ang II AT 2 -receptor antagonist, P-186 (10 -7 M), was added to the fibroblast cultures, it had no effect on the Ang II-evoked increase in collagen secretion and production; when P-186 was added together with telmisartan, the Ang II-induced increases in collagen secretion and production were, however, inhibited.
Effect of Ang II receptor antagonists on Ang II-induced increase in non-collagen secretion and production
Telmisartan, but not P-186, blocked the Ang IIinduced increase in non-collagen secretion and production ( Figures 5 and 6 ). Pretreatment of cardiac fibroblasts with telmisartan plus P-186 also inhibited the Ang II-evoked increase in non-collagen secretion and production.
Discussion
The present results show that administration of Ang II increases collagen secretion and production in vitro in adult rat cardiac fibroblasts in culture and that this effect is blocked by the Ang II AT 1 -receptor antagonist, telmisartan, but not by the Ang II AT 2 -receptor antagonist, P-186. An Ang IIinduced increase in collagen has been demonstrated in vitro in cultured rat vascular smooth muscle cells from thoracic aortae, 22 in cultured murine mesangial cells, 23, 24 in cultured rat glomerular cells 25 and in cultured adult rat cardiac fibroblasts in a concentration-dependent manner (Figures 1 and 2 ; Table 1 ). However, large concentrations (10 -7 -10 -6 M) of Ang II are required.
Ang II increases cardiac fibroblast-mediated total collagen synthesis by inhibition of matrix metalloproteinase (MMP-1) activity. 16 Ang II also induces tissue inhibitor of MMP-1 gene expression in rat heart endothelial cells. 26 Besides the stimulation of collagen synthesis, Ang II also increases mRNA levels of collagen type I, type III, pro-α 1 (I) collagen, pro-α 1
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Figure 2
Concentration-response curve for the angiotensin II-induced changes in non-collagen secretion and production in adult cardiac fibroblasts in culture. (III) collagen and fibronectin 14, 15, 17, 27 in cultured cardiac fibroblasts.The Ang II-induced expression of type I collagen mRNA is also completely abolished by AT 1 -receptor antagonism, 14, 17, 28, 29 but is unaffected by AT 2 -receptor antagonism.
In vivo, Ang II infusions at pressor or subpressor doses in rats also induces an increase in collagen and fibronectin. 30, 31 The presence of high numbers of Ang II AT 1receptors on neonatal and adult rat cardiac fibroblasts has been documented. 14, 15, [32] [33] [34] AT 1 -receptors exhibit saturable, reversible and high affinity (K d = 0.4-1 nM) binding of Ang II, that is competed for by non-peptide AT 1 -receptor antagonists, Ang I and Ang III.
Competitive binding studies employing nonpeptide receptor antagonists for AT 2 -receptors, failed to detect their presence in either neonatal or adult cardiac fibroblasts, 14, 15, 33 although Ang II inhibition of collagenase activity in adult rat cardiac fibroblasts was attenuated only by AT 2 -receptor blockade. 16 Of the two AT 1 -receptor subtypes expressed in the rat, cardiac fibroblasts express much higher mRNA levels for the AT 1A than the AT 1B receptor. 34 Adult rat cardiac fibroblasts express higher mRNA levels for the AT 1 -receptor than do neonatal cardiac fibroblasts.
The expression of Ang II receptors by left ventricular fibroblasts exhibits, however, marked species dependence. Cultured rat fibroblasts express 43,000±15,000 Ang II (AT 1 -specific) receptors per cell, whereas rabbit and neonatal human cardiac fibroblasts express fewer such receptors. 35 However, in isolated human cardiac fibroblasts, Ang II itself does not increase collagen I mRNA directly but through indirect pathways that may involve TGF-β 1 and osteopontin. 36 The ability of Ang II to induce collagen synthesis and expression of collagen in rat cardiac fibroblasts may be mediated by an increased TGF-β 1 production in an autocrine/paracrine fashion. Indeed, cardiac fibroblasts are the principal cellular origin of TGF-β 1 and in cultured rat adult cardiac fibroblasts, Ang II stimulates TGF-β 1 gene expression, increases total TGF-β 1 production and promotes the conversion of latent TGF-β 1 to the active form. 32, [37] [38] [39] [40] [41] Simultaneous treatment of cardiac fibroblasts in vitro with Ang II and neutralising antibody to TGF-β 1 has been shown to reduce type I and type III collagen mRNA expression. 42 Ang II-stimulated TGF-β 1 secretion is greatly attenuated by a AT 1 -receptor antagonist. 42 We have also demonstrated that TGF-β 1 induces the differentiation of cultured rat ventricular fibroblasts to myofibroblasts and this differentiation is accompanied by an increase in angiotensin converting enzyme (ACE) activity and protein and by a profound modification of the fibroblast phenotype, which consists of a change in cell morphology, an enlargement of cell volume and an increase in cell protein content. 43 Moreover, the effects of Ang II and TGF-β 1 are also complementary in vivo. Both of them induce cardiac fibrosis which, independent of the primary stimulus, is accompanied by high tissue concentrations of both Ang II and TGF-β 1 [44] [45] [46] and by the appearance of ACE and myofibroblasts. 45, [46] [47] [48] [49] [50] Both TGF-β 1 and ACE, as a means of Ang II synthesis, are thus involved in the enhancement of cardiac tissue fibrosis and these factors can create a vicious circle in the fibrotic tissue. The molecular interactions between Ang II and TGF-β 1 and the synthesis and secretion of adhesion molecules,extracellular matrix proteins and the expression of integrin adhesion receptors in the development of cardiac fibrosis have however to be further elucidated. 
